Abstract
Promises of far greater transparency and access to clinical trial data set out in new drug industry-wide principles have been met with scepticism by clinicians and researchers. Two of the...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
